Skip to main content
Clinical Trials/CTRI/2024/06/069452
CTRI/2024/06/069452Not yet recruitingPhase 3

Clinical study on Taakul e Unq ur Rahem (Cervical Erosion) and its management with Chui Mui (Mimosa Pudica)

Government Nizamia Tibbi College and General Hospital1 site in 1 country30 target enrollmentStarted: June 30, 2024Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
To test the efficacy of mimosa pudica in the treatment of Cervical Erosion.

Study Overview

Brief Summary

A single blind clinical study on cervical erosion and its management with unani formulation

Cervical Erosion is one of the most common benign gynaecological lesions of cervix. 3 out of 4 adult parous women suffer from this disease,with symptoms like Backache ,lower abdominal pain ,white discharge ,contact bleeding as the cervix becomes fragile and menstrual disorders like  metrorrhagia dysmenorrhoea, menorrhagia, UTI, dyspareunia.

Diagnosis:

GENERAL EXAMINATION: Parous woman in childbearing age are common victims. General health may be poor, Slight anaemia is present.

VAGINAL EXAMINATION: 1.Bimanual Examination

2.Speculum Examination

Investigations  include:

1.CBP

2.ESR

3.CUE

4.RBS

4.LFT

5.RFT

SPECIAL INVESTIGATIONS:

  1. VDRL

2.Cervical pap smear

Study Design

Study Type
Interventional
Allocation
Na
Masking
Participant Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Married women with different age group,parity and Socio economic status.
  • Married women with sign and symptoms of Cervical Erosion.

Exclusion Criteria

  • Pregnant Women.
  • Doubtful or confirmed Malignancy.
  • Uterine pathologies like fibroid,prolapse or endometritis.

Outcomes

Primary Outcomes

To test the efficacy of mimosa pudica in the treatment of Cervical Erosion.

Time Frame: 10th day of each cycle for maximum 3 cycles

Secondary Outcomes

  • Resolution of cervical erosion(10th day of each cycle for 3 cycles)

Investigators

Sponsor
Government Nizamia Tibbi College and General Hospital
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Humena Iffath Khatoon

Kaloji Narayan Rao University of Health sciences

Study Sites (1)

Loading locations...

Similar Trials